INTRODUCTION
The molecular mechanism of general anesthesia remains poorly understood after more than a century of investigation (1) . Anesthetics interact with many transmembrane ion channels and soluble proteins often causing unwanted side effects. Gaining a detailed understanding of the motifs governing anesthetic-protein interactions is a critical step both in elucidating the molecular mechanisms underlying general anesthesia and in developing more selective anesthetic agents. However, little progress can be made until such sites have been unequivocally identified. Unfortunately, this has proved to be a difficult task. Most structural information has been obtained in soluble proteins such as myoglobin, hemoglobin, adenylate kinase, luciferase, human serum albumin and insulin (2-7). These surrogate targets are being used because the structures of membrane proteins, the likely physiological targets of general anesthetics, are difficult to determine. Photoaffinity labeling is an alternative method for locating sites that can be applied to any protein (8) . Typical general anesthetics are relatively small drugs that include hydrocarbons, ethers and alcohols making aliphatic diazirines an attractive choice for developing general anesthetic photolabels. In spite of the early fears about the photochemistry of aliphatic, as opposed to aromatic, diazirines (9,10), they have now been successfully employed in the design of minimally perturbing by guest on September 1, 2017 http://www.jbc.org/ Downloaded from photoaffinity probes (11, 12) . We, therefore, recently developed a novel photoreactive aliphatic diazirine-containing general anesthetic: 3-(2-Hydroxyethyl)-3-n-pentyldiazirine (3-azioctanol) (13) . [ 3 H]3-Azioctanol and traditional sequencing methods have been used to identify a site within the ion channel domain of the acetylcholine receptor where photoincorporation is dependent on the receptor's conformational state (14) .
In this work, we introduce two new strategies to increase the information yielded by photolabeling. First, in order to explore the orientation and conformation of the bound ligand and the extent of its binding pocket, we used a pair of geometric isomers (3-and 7-azioctanol, Fig. 1 ). This appears to be the first application of this strategy (15) .
Second, in order to investigate the role of ligand size, we halved the length of the aliphatic chain while keeping the relationship between the hydroxyl and diazirine groups constant (3-azioctanol verses 3-azibutanol). We chose first to explore an unknown anesthetic site in a protein whose structure is well established in order to provide a stringent test of the strategies before applying them to excitable membrane proteins, which are the likely targets of general anesthetic action.
Adenylate kinases catalyze the transfer of a phosphoryl group by the reaction ATP.Mg 2+ + AMP <=> Mg 2+ + 2ADP (16) . Their structures have been intensively studied and the conformational changes that accompany catalysis are well characterized by guest on September 1, 2017 http://www.jbc.org/ Downloaded from (17, 18) . All adenylate kinases share a similar three-domain structure (Fig. 2) . They have a central domain (CORE) consisting of a five stranded parallel β-sheet surrounded by α-helices, an α-helical nucleotide monophosphate binding (NMPbind)
domain and a region that covers the active site during catalysis (LID) (17, 18) . Halothane inhibits muscle adenylate kinase (myokinase), an action once implicated in general anesthetic-induced malignant hypothermia, and its binding site has been identified (4).
At ~22 kDa the small variant adenylate kinases are considerably smaller than the much-studied surrogate anesthetic target, luciferase (MW ~72kDa), allowing us to apply the full power of mass spectrometry. This technique can directly yield the mole fraction of even the smallest covalently incorporated ligands, such as nitric oxide (19) , and it allows identification of sites of photoincorporation without the necessity for synthesizing radiolabeled ligands.
EXPERIMENTAL PROCEDURES
Materials. Chicken adenylate kinase and Ap5A were from Sigma (St. Louis, MO).
Modified trypsin was obtained from Boehringer Mannheim (Indianapolis, IN). 3-azioctan-
1-ol and [ 3 H]3-azioctan-1-ol (specific activity 11 Ci/mmol) were synthesized and characterized as described (13) . 3-azibutan-1-ol was synthesized as previously reported (20) . All other reagents were obtained from Aldrich.
Synthesis of 7-Azioctanol. 7-Azioctanol was synthesized via the sequence of reactions shown in Figure 3 . The 2-hydroxytetrahydropyran 2 was prepared as described in (21) . Hydroxy-3-octen-7-one 4 was synthesized from 2-hydroxytetrahydropyran by Wittig reaction with phosphoniumtriphenyl-2-oxopropylide.
A suspension of 2-hydroxytetrahydropyran (3.2 g, 31.4 mmol) and phosphoniumtriphenyl-2-oxopropylide (10 g, 31.4 mmol) in anhydrous benzene (100 ml) was refluxed for 5 h and then stirred overnight at room temp. After removing the solvent by rotary evaporation, the residue was extracted with hexane (3 x 100 ml). The combined extract was applied to a column of silica gel (70 g), equilibrated with Hydroxyoctan-7-one 5 was prepared by reduction of hydroxy-3-octen-7-one (1 g, 7 mmol) with hydrogen in the presence of 5% Pd-carbon (1 g) in dry ethylacetate (30 ml) for 24 h. The 7-azioctanol 6 was synthesized in 39 % yield from hydroxyoctan-7-one essentially by the procedure described for the synthesis of 3-azioctanol (13) . The UV spectrum in dichloromethane had a λ max of 348 nm, characteristic of the diazirine group (20) . This result is the charge state of the ion with the higher m/z of the two adjacent peaks.
To calculate the unprotonated molecular mass the determined charge state is multiplied by the ion's mass/charge then the charge state subtracted from the product. Vydac C18 column (4.6 mm x 250 mm) and eluted with a 40 minute gradient of 0-80% acetonitrile in 0.1 % TFA at a flow-rate of 1 mL/min. Eluent was monitored at 214 nm and 1 mL fractions were continuously collected. Tritium containing samples were assayed by scintillation counting; all others were analyzed by mass spectrometry as described below. 
Determination of Molecular Mass of Proteolytic Fractions by

Determination of Mole Ratio of Photoincorporation into Adenylate Kinase by LC/MS.
Stoichiometry of photoincorporation of 3-azioctanol into adenylate kinase was determined using online microcapillary liquid chromatography coupled to an ion trap mass spectrometer with electrospray ionization. Although complete separation of unlabeled and labeled adenylate kinase was not achieved on the HPLC column, peak heterogeneity does not prevent molecular mass determination of the co-eluted proteins because of their unique charge envelopes. The ion chromatogram for this reaction mixture can be seen in Figure 5A . Figure 5B shows the charge envelope eluting between 8.8 and 12.0 minutes. This is obtained by summing the spectra acquired approximately every second during this time period. Deconvolution of the mass/charge ratios yields a main peak with maximum molecular mass of 21,595, corresponding to unmodified adenylate kinase, and a secondary peak of molecular mass 21,723 Da ( There is also a rather broad signal of low intensity, which includes the molecular mass corresponding to a stoichiometry of 2:1. This peak probably does not represent photoincorporation of a second azioctanol because it was not observed consistently, sometimes being absent even at 1 mM azioctanol, and because only a single tryptic peptide bearing [ 3 H]3-azioctanol was detected by HPLC.
Photoincorporation of 7-azioctanol into adenylate kinase was determined similarly (Fig. 6) . Deconvolution of the charge envelope eluting between 8.3 and 11.0 minutes clearly showed that 7-azioctanol is also photoincorporated into adenylate kinase at a mole ratio of 1:1. Once again there is a broad peak of weak intensity including the molecular mass equivalent to a stoichiometry of 2:1.
Photoincorporation of 3-azibutanol into adenylate kinase was also determined by microcapillary LC/MS with electrospray ionization as described above. The charge envelope was deconvoluted to yield a series of peaks. The first corresponded to unlabeled adenylate kinase, and the succeeding peaks were shifted successively by 72
Da from 21,667 Da to 21,954 Da, revealing photoincorporation at mole ratios up to 5:1 (Fig. 7) . When the 3-azibutanol concentration was increased from 0.1 to 1.0 mM, deconvolution yielded five peaks all with ion currents higher than the unlabeled peak, suggesting very efficient photolabeling. Under these conditions a peak corresponding to a mole ratio of 6:1 was just detectable (Fig. 7) . indicating that His-36 is not the site of photoincorporation (Fig. 9) . Thr-39 (b8) and Gly-40 (b9) are not observed. The series b10 to b12 are observed to be modified, having the spacing and absolute position observed previously (Fig. 8) . The y3 ion with at its N-terminus is observed to be unmodified, whereas y4 (m/z 642.6) and all observed higher ions are modified. Thus, this site of photoincorporation is at Asp-41. In the minor fraction, His-36 was identified as the site of attachment (data not shown). 
DISCUSSION
The 3-azioctanol photoincorporated into His-36 selectively with an apparent dissociation constant of 180 µM (Fig. 4) , which is remarkably close to the concentration causing general anesthesia in vivo (160 µM; (13)). This was unexpected because in earlier studies on adenylate kinase activity volatile anesthetics acted only at supraclinical concentrations (22) . One mole of 3-azioctanol was photoincorporated per mole of adenylate kinase with a yield of 18%. The facility with which mass spectrometry provided the mole ratio of photoincorporation is encouraging because the low affinity of general anesthetics makes such estimates difficult. In serum albumin, for example, binding studies estimated the general anesthetic propofol to have many saturable sites (23), whereas subsequent structural determination found only two (6). However, there are some limitations to the mass spectrometric method. In particular, as the efficiency of photoincorporation decreases it becomes increasingly difficult to rule out the occurrence of mole ratios higher than one because the probability of observing them would be the product of the probabilities of observing the singly labeled species. Even at 1 mM, only 18% of the kinases photoincorporated one mole of [ 3 H]azioctanol, and it was difficult to entirely rule out photoincorporation of a second azioctanol. In contrast, azibutanol clearly photoincorporated at several mole ratios (Fig. 7) and raising its concentration to 1 mM skewed the distribution even further towards the higher ratios.
The strategy of placing diazirine groups on both the 3-and 7-positions of octanol was remarkably successful, leading to the identification of two amino acids separated by four residues. A three dimensional structure of chicken adenylate kinase is not available, but the high-resolution structure of porcine adenylate kinase (24) can serve as a good model because the two enzymes have high sequence identity (86.4%) and can be expected to assume almost identical structures (16, 25) . Therefore, the following analysis is based on the structure of the unliganded porcine enzyme and uses that protein's numbering scheme. All residues discussed herein are identical in the porcine and chick enzymes. Inspection of the crystal structure shows the distance between the α-carbons of His-36 and Asp-41 to be about 10 Å and the closest approach of their side chains to be ~5Å (Fig. 11A) . The maximum distance between the third and seventh carbons of a fully extended aliphatic chain is 5.2 Å (Fig. 1) . The matching of these distances suggests that the octanol chain binds in a mostly extended conformation with its third carbon near His-36 and its seventh carbon near Asp-41. This observation defines the orientation of the octanol backbone relative to the structure of adenylate kinase. Apparently, the hydroxyl interacts strongly enough with residues in the binding pocket to ensure that both the 3-azialkanols photolabel only the histidine. Inspection suggests two locations where the alkanol hydroxyl might hydrogen bond to the protein.
These are the backbone carbonyl of Tyr-34 ( Fig. 11A ) and both Glu-26 and Asp-93 (Fig.   11B ). On the other hand, the hydrophobic end of the azioctanol is less well constrained allowing 7-azioctanol to sometimes label the histidine as well as the aspartate.
Both the residues in the octanol binding site (His-36 and Asp-41) are very highly conserved in all mammalian adenylate and uridylate kinases (16) . His-36 is part of the CORE domain and is located in strand 2 at the edge of the five stranded central β-sheet (Fig. 2) (16, 26) . Asp-41 is on the first turn of the second α-helix and belongs to the NMPbind domain. Thus, this anesthetic site is located in a cleft between two structural domains.
The conformational changes accompanying the catalytic cycle of adenylate kinase are structurally well characterized (17, 18) . A useful ligand employed in many of these studies is the substrate-micking inhibitor, Ap5A. This symmetrical inhibitor connects adenosine monophosphate (AMP) and adenosine triphosphate (ATP) by a fifth phosphate, mimicking both bound substrates (25, 27 A low-resolution difference Fourier map of a halothane-adenylate kinase complex (4) showed that halothane (CF 3 .CHClBr) bound to the CORE domain between the central β-sheet (strands 1, 4 and 5) and helix α1, in an area distant from the alkanol binding site identified in this work. Thus halothane and alkanols appear to target distinct sites in adenylate kinase. Interestingly, separate sites for these two anesthetics have also been observed in acetylcholine receptors (14, 29) .
Crystallographic studies suggest that anesthetics bind in well-defined pockets that have relatively rigid size constraints and that exclude larger agents that could only fit if more than slight rearrangements of their amino acid side chains occurred (2, 3, 30, 31) .
Consequently, one would expect that the number of anesthetic binding pockets on a given protein would tend to increase as the size of the agent decreases (6, (32) (33) (34) . Our results with 3-azibutanol are consistent with this hypothesis because it incorporated with a much higher stoichiometry than the azioctanols. In addition to binding the pocket at
His-36, 3-azibutanol also photoincorporated into both Tyr-32 and Tyr-34 in the CORE domain (Fig. 2) . These residues form a small aromatic pocket at the base of the enzyme, between helices α1 and α8 (Fig 2) , that plausibly might exclude azioctanols.
The domains has been noted in some other cases (6, 36) and may prove to be a common motif for general anesthetic binding sites.
In conclusion, this work demonstrates that geometric isomers of aliphatic diazirines can be used to delineate ligand binding pockets in proteins. On adenylate kinase, 3-and 7-azioctanol identified two residues separated by 5Å, corresponding to the distance between the third and seventh carbon of an extended aliphatic chain (Fig. 11 ). These residues are in different domains that move relative to each other when a substrate is bound. The strategy should be applicable to other likely targets of general anesthetics such as excitable membrane proteins. In the orientation shown, the octanol hydroxyl would be able to interact favorably with the sidechains of Glu-26 or Asp-93, and/or with carbonyl oxygens in α1. 
